GleamWall
中文EN

TRXB TRex Bio, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 2139097 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets15.8%
Debt / equity—
Current ratio7.58x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue——————
R&D expense$11.43M——$6.97M——
SG&A expense$2.49M——$1.74M——
Operating income-$13.92M——-$8.71M——
Pretax income-$13.15M——-$7.86M——
Income tax$88,000——$0——
Net income-$13.24M-$13.09M-$16.22M-$7.86M-$8.33M-$9.39M
EPS (basic)-10.06——-7.58——
EPS (diluted)-10.06——-7.58——
Weighted avg. shares (diluted)1.32M——1.04M——
Balance sheet
Cash & equivalents$16.81M——$25.79M——
Short-term investments$61.34M—————
Current assets$79.85M—————
PP&E, net$826,000—————
Total assets$88.75M—————
Current liabilities$10.53M—————
Total liabilities$14.03M—————
Shareholders' equity-$134.11M-$121.21M-$108.26M-$83.20M-$75.51M-$67.32M
Shares outstanding1.50M—————
Cash flow statement
Operating cash flow——————
Stock-based compensation$178,000——$129,000——

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.